Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/1998
03/03/1998US5723444 Enzyme inhibitors and anticoagulants
03/03/1998US5723327 Hydrolyzes oligo- and polysaccharides with trehalose end unit; culturing sulfobus; foods, cosmetics, drugs
03/03/1998US5723315 Secreted proteins and polynucleotides encoding them
03/03/1998US5723148 Topical pharmaceutical compositions
03/03/1998US5723144 Ointment for wound treatment
03/03/1998US5723139 Skin conditioner mixture of retinoid esters with polycyclic triterpene carboxylic acids for cosmetics
03/03/1998US5723109 Use of salicyclic acid derivatives for depigmenting the skin
03/02/1998CA2213690A1 Use of retinoid in preparing a medication to treat disorders related to overexpression of vegf
02/1998
02/26/1998WO1998007859A2 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007833A1 Compositions and methods for use of defensin
02/26/1998WO1998007697A1 Arylsulfonylamino hydroxamic acid derivatives
02/26/1998WO1997044007A3 A barrier cream comprising hexamethylenetetramine or derivative thereof
02/26/1998WO1997039123A3 Secreted proteins
02/26/1998WO1997038966A3 Cytoprotective compounds
02/26/1998CA2264284A1 Arylsulfonylamino hydroxamic acid derivatives
02/26/1998CA2264203A1 Compositions and methods for use of defensin
02/26/1998CA2264192A1 Secreted proteins and polynucleotides encoding them
02/26/1998CA2264064A1 Imidazole compounds, compositions and use
02/26/1998CA2213106A1 Tocopheryl ascorbyl phosphate-cyclodextrin clathrate and a topical dermal composition containing said clathrate
02/25/1998EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque
02/25/1998EP0824544A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
02/25/1998EP0824543A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
02/25/1998EP0824354A1 Methods to inhibit late radiation-induced skin damage
02/25/1998EP0824353A1 Methods to inhibit acute radiation-induced skin damage
02/25/1998EP0824348A1 Treatment of psoriasis with 11-cis-retinoic acid
02/25/1998CN1174194A Novel derivative of kojic acid and its use as depigmenting agent
02/24/1998US5721254 Antiinflammatory agents; analgesics
02/24/1998US5721225 Skin disorders; osteoporosis
02/24/1998US5721224 Method of treating metabolic bone diseases with 18-nor-vitamin D compounds
02/24/1998US5720966 Medicated tissue paper product
02/19/1998WO1998006846A1 Human induced tumor protein
02/19/1998WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12)
02/19/1998WO1998006830A1 Synthetic polynucleotides
02/19/1998WO1998006740A1 Dipeptide benzamidine as a kininogenase inhibitor
02/19/1998WO1998006703A1 2-phenyl benzimidazole derivatives as mcp-1 antagonists
02/19/1998WO1998006701A1 Il-8 receptor antagonists
02/19/1998WO1998006412A1 A medicine of external use for treating seborrheic baldness with high efficacy and low side effect and preparation thereof
02/19/1998WO1998006406A1 Mannose-6-phosphate composition and its use in treating fibrotic disorders
02/19/1998WO1998006397A1 Il-8 receptor antagonists
02/19/1998WO1998006262A1 Il-8 receptor antagonists
02/19/1998WO1998001124A3 Pharmaceutical preparation containing nimesulide for topical use
02/19/1998WO1997046208A3 Genistein as a preventive against ultraviolet induced skin photodamage and cancer
02/19/1998DE19632772A1 Neue Benzamidine New benzamidines
02/19/1998CA2263388A1 Il-8 receptor antagonists
02/19/1998CA2263344A1 Dipeptide benzamidine as a kininogenase inhibitor
02/19/1998CA2263165A1 Human induced tumor protein
02/19/1998CA2263143A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
02/19/1998CA2261572A1 Lysyl oxidase synthetic polynucleotides
02/18/1998EP0823903A1 Heterocyclic diaryl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof
02/18/1998EP0823895A1 Fatty acid esters as bioactive compounds
02/18/1998EP0823889A1 1,3-propane diol derivatives as bioactive compounds
02/18/1998EP0823848A1 Tissue adhesive using synthetic cross-linking
02/18/1998CN1173818A Pharmaceutical preparations for tumour necrosis factor (TNF) inhibition
02/18/1998CN1173497A Heterocycle-containing carbonic acid derivatives
02/18/1998CN1173324A Photostable screening composition comprising dibenzoylmethane derivative and polysaccharide alkyl ether, and uses thereof
02/17/1998US5719306 LTA4 hydrolase inhibitors
02/17/1998US5719175 Protein kinase C inhibitors
02/17/1998US5719164 Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
02/17/1998US5719158 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
02/17/1998US5719129 Sunscreen agents, antiaging agent, free radical scavenger
02/17/1998US5718899 High concentration of immunoglobulins
02/17/1998US5718897 Contacting with purified clostridiopeptidase a collagenase and a growth factor to increase effects of collagenase
02/17/1998US5718865 Shaping a graunlated alum and plasticizer mixture
02/12/1998WO1998005779A1 Modified tie-2-receptor ligands
02/12/1998WO1998005654A1 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals
02/12/1998WO1998005637A1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a¿2?
02/12/1998WO1998005635A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
02/12/1998WO1998005340A1 Promotion of wound healing by chemically-modified tetracyclines
02/12/1998WO1998005338A2 Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
02/12/1998WO1998005317A1 Il-8 receptor antagonists
02/12/1998WO1998005313A1 Composition comprising mupirocin and chlorhexidine
02/12/1998WO1998000129A3 Anticonvulsant derivatives useful in treating psoriasis
02/12/1998WO1997019111A3 Monoclonal antibodies anti-cd6 and their uses
02/12/1998DE19642872C1 Use of sterol sulphate compounds to inhibit serine protease
02/12/1998CA2263154A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
02/12/1998CA2262430A1 Composition comprising mupirocin and chlorhexidine
02/11/1998EP0822812A1 Topical treatment and/or prevention of sagging subcutaneous muscle and overlying cutaneous tissue using acetylcholine precursors and catecholamines
02/11/1998EP0822803A1 Cosmetic agent with an ilex resin content, process for extraction of ilex resin and ilex resin obtained thereby
02/11/1998CN1172793A 1, 25 -dihydroxy -16, 22, 23 -trisdehydro-chdecalciferol derivatives
02/11/1998CN1172674A Chinese medicinal herb composition for treating skin disease
02/11/1998CN1172638A Cosmetics containing brown grape and ginseng composition
02/10/1998US5716994 Plant extracts
02/10/1998US5716986 Lipoxygenase inhibitors
02/10/1998US5716967 Isoxazoline compounds as antiinflammatory agents
02/10/1998US5716959 Administering substituted piperazines having hydroxy- or amino-alkyl groups on one nitrogen and carboxylic, phosphoric or sulfonic alkyl groups on the other nitrogen, for treatment of cancer and autoimmune diseases
02/10/1998US5716955 Cytokine inhibitor
02/10/1998US5716945 Antiinflammatory agents; immunostimulation; cell differentiation; antigrowth agents
02/10/1998US5716935 Applying polypeptide in carrier to wound to accelerate healing
02/10/1998US5716800 Anti-acne composition containing a Poria cocos wolf extract
02/10/1998US5716632 Administering n-substituted 2-(1h)pyridones or 3-(1h)pyridones
02/10/1998US5716624 Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof
02/10/1998US5716620 Vaccines, diagnostic immunoassay
02/10/1998US5716608 Methods to inhibit acute radiation-induced skin damage
02/10/1998US5716607 Preapplying a layer of biocompatible polymer
02/10/1998US5716605 Using alcoholic solution of oat extract
02/05/1998WO1998004714A1 A NOVEL HUMAN mRNA EDITING ENZYME
02/05/1998WO1998004694A2 Secreted proteins and polynucleotides encoding them
02/05/1998WO1998004534A1 6-phenyltetrahydro-1,3-oxazin-2-one derivatives and medicinal compositions containing the same
02/05/1998WO1998004281A1 Improved method of treating immune cell mediated systemic diseases
02/05/1998WO1998004279A1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin